Triplet therapy with bortezomib, lenalidomide and dexamethasone — a regimen often referred to as VRd — is a current standard ...

Despite resubmitting after an initial complete response letter (CRL) due to manufacturing issues, the combination therapy ...

And yet he was unable to access treatment, before a community healthcare worker stepped in. This real testimony underpins the critical importance of frontline healthcare workers and the model of ...

An expert discusses how in the first-line (1L) treatment of advanced unresectable hepatocellular carcinoma (uHCC) with tyrosine kinase inhibitors (TKIs) such as lenvatinib or sorafenib, proactive ...

“This condition has a high mortality rate, so timely and effective treatment is crucial for ... Tong was quickly called to the frontline when COVID-19 first emerged in Wuhan in late 2019.

Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.

Until now, oncologists had no reliable way to determine which of the two most widely used chemotherapy regimens for frontline treatment of newly diagnosed pancreatic cancer—FOLFIRINOX (FFX ...

Aptevo Therapeutics reports strong remission rates in AML patients using mipletamig plus ven/aza, with Cohort 2 enrollment ...